Trinity Biotech (TRIB) Other Non-Current Liabilities (2009 - 2025)
Trinity Biotech (TRIB) posted Other Non-Current Liabilities of $781000.0 for Q4 2025, down 57.58% sequentially from $1.8 million in Q2 2025, and up 941.33% YoY from $75000.0 in Q4 2024.
Trinity Biotech (TRIB) Other Non-Current Liabilities (2009 - 2025) Analysis & Trends
Trinity Biotech has reported Other Non-Current Liabilities for 17 years, with the latest figure at $781000.0 in Q4 2025.
- Quarterly Other Non-Current Liabilities rose 941.33% year-over-year to $781000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $781000.0 (up 941.33% YoY) and the FY2025 annual result came in at $781000.0, up 941.33% from the prior year.
- Other Non-Current Liabilities eased to $781000.0 in Q4 2025 per TRIB's latest filing, from $1.8 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $1.8 million in Q2 2025 and troughed at $50000.0 in Q4 2021.
- A 5-year average of $245833.3 and a median of $50000.0 in 2021 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2025: Other Non-Current Liabilities sank 87.98% in 2021, then soared 3582.0% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $50000.0 in 2021, then changed by 0.0% to $50000.0 in 2022, then changed by 0.0% to $50000.0 in 2023, then jumped by 50.0% to $75000.0 in 2024, then jumped by 941.33% to $781000.0 in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $781000.0, $1.8 million, and $75000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 781,000.00 |
| Jun 30, 2025 | 1.84 Mn |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 376,000.00 |
| Jun 30, 2021 | 376,000.00 |
| Mar 31, 2021 | 376,000.00 |
| Dec 31, 2020 | 416,000.00 |
| Sep 30, 2020 | 50,000.00 |